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Objectives. This study sought o optimize preoperative cardiac 
risk stratification i  a large group of consecutive candidates for 
vascular surgery by combining clinical risk assessment and 
semiquantitative dobutamine-atropine str ss echocardiography. 
Background. Dobutamine-atropine stress echocardiography 
has been used for the prediction of perioperative cardiac risk in a 
small group of patients scheduled for elective major vascular 
surgery on the basis of the presence or absence of stress-induced 
regional left ventricular wall motion abnormalities. 
Methods. Clinical risk assessment and dobutamine-atropine 
stress echocardiography were performed in 302 consecutive pa- 
tients presenting for major vascular surgery. The extent and 
severity of stress wall motion abnormalities and the heart rate at 
which they occurred, in addition to the presence of wall motion 
abnormalities at rest, were assessed. 
Results. The absence of clinical risk factors (angina, diabetes, 
Q waves on the electrocardiogram, symptomatic ventricular 
tachyarrhythmias, age >70 years) identified a low risk group 
of 100 patients with a 1% cardiac event rate (unstable angina). 
Dobutamine-atropine stress echocardiographic f ndings were 
positive in 72 patients. Twenty-seven patients had a perioperative 
cardiac event (cardiac death in 5, nonfatal infarction in 12, 
unstable angina pectoris in 10); all 27 patients had positive stress 
test results (positive predictive value 38%, negative predictive 
value 100%). The semiquantitative assessment ofthe extent and 
severity of ischemia did not provide additional prognostic infor- 
mation in patients with positive test results. In contrast, he heart 
rate at which ischemia occurred efined a high risk group with a 
low ischemic threshold (38 patients with 20 events [53%]) and an 
intermediate risk group with a high ischemic threshold (34 
patients with 7 events [21%]). All 5 patients with a fatal outcome 
and 8 of 12 with a nonfatal myocardial infarction were in the high 
risk group with a low ischemic threshold. 
Conclusions. Clinical variables identify 33% of patients at very 
low risk for perioperative complications of vascular surgery in whom 
further testing is redundant. In all other candidates, dobutamine- 
atropine stress echocardiography is apowerful tool that identifies 
those patients at intermediate risk and a small group at very high 
risk. Risk stratification with a combination of clinical assessment 
and pharmacologic stress echocardiography has the potential to 
facilitate clinical decision making and conserve resources. 
(J Am Coil Cardiol 1995;26:648-53) 
Perioperative cardiac complications are a leading cause of 
morbidity and mortality in patients undergoing major vascular 
surgery (1-4). For example, elective resection of an abdominal 
aortic aneurysm is associated with an operative mortality rate 
of 3% to 10% (2), with -50% of deaths cardiac in origin. 
Effective preoperative risk stratification has the potential to 
facilitate decision making by enabling patients and physicians 
to better assess the risk/benefit ratio of proposed surgical 
procedures. Furthermore, unequivocal identification of a low 
risk group would permit their expeditious and cost-effective 
surgical management. 
Several techniques for preoperative cardiac risk assessment 
From the Thoraxccntrc and Department t~f Vascular Surgel)', Erasmus 
University, Rotterdam, The Netherlands. Dr. Thomson was on sabbatical lcavc 
from the University of Manitoba, Winnipeg, Manitoba, Canada. 
Manuscript received December 21, 1904: revised manuscript received April 
14, 1995, accepted May 1, 1995. 
Address for correspondence: Dr. Paolo M. Fioretti. Thoraxcentre, Room Ba 
300, Academisch Ziekenhuis Dijkzigt, Dr Molewaterplein 4[]. 31115 GD Rotter- 
dam, The Netherlands. 
have been advocated. These include clinical evaluation (5-7), 
exercise electrocardiography (8), ambulatory electrocar- 
diography (9,10), radionuclide ventriculography (11) and 
dipyridamole-thallium scintigraphy (12-14). Of these, 
dipyridamole-thallium myocardial perfusion scintigraphy has 
been most widely advocated. However, recent studies (15) 
have found dipyridamole-thallium scintigraphy to have poor 
predictive power and suggest that its routine use may not have 
been justified. 
More recently, pharmacologic stress echocardiography with 
dobutamine or dipyridamole has been proposed as an alterna- 
tive to dipyridamole-thallium scintigraphy for risk assessment 
in candidates for vascular surgery (16-21). This technique uses 
transthoracic e hocardiography to detect ischemic left ventric- 
ular wall motion abnormalities induced by pharmacologic 
stress. Preliminary studies uggest that stress echocardiography 
is a safe (22) and sensitive technique for predicting periopera- 
rive cardiac events and has excellent negative predictive power 
(16-21). However, these previous tudies had limitations: 1) 
Most did not enroll patients consecutively, so a referral bias 
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may have been present. 2) Clinicians caring for the patients 
usually had access to test results, and this may have altered 
management. In some studies, apparently high risk patients 
underwent coronary angiography or myocardial revasculariza- 
tion, or both, before vascular surgery. 3) A relatively small 
number of patients were studied. 4) Test results were classified 
simply as positive or negative, without including information 
about the extent and severity of inducible ischemia or the 
threshold heart rate at which ischemia developed. This latter 
defect might explain the relatively low positive predictive 
power of stress echocardiography in some studies (16,17). We 
attempted to overcome these limitations by evaluating the 
predictive power of dobutamine-atropine str ss echocardiog- 
raphy in a large group of consecutive patients while blinding 
clinicians to test results. We also attempted to improve the 
predictive power of the test by using a quantitative approach 
that utilizes more of the information available from the test. 
This report represents an extension of our previous 136 
consecutive patients (21). 
Methods  
Patient characteristics. Three-hundred two consecutive 
patients cheduled for elective major vascular surgery were 
studied uring a 3-year period from 1991 to 1994. All patients 
were judged not suitable to be assessed by exercise testing. 
After a detailed history, physical examination and 12-lead 
electrocardiogram (ECG), Detsky's modification of Goldman 
cardiac risk index was calculated for each patient. By the 
method of Eagle et al. (13), the number of clinical risk factors 
(angina, diabetes requiring drug therapy, age >70 years, Q 
wave on the ECG and history of ventricular ectopic activity 
requiring treatment) present in each subject was counted. 
Minimal additional preoperative t sting or therapy was under- 
taken. Three patients underwent dipyridamole-thallium myo- 
cardial scintigraphy, and none bad coronary angiography or 
prophylactic myocardial revascularisation before operation. 
Dobutamine-atropine stress test. The study protocol was 
approved by the hospital ethics committee, and all patients 
gave informed consent. No anti-ischemic medication was with- 
drawn before testing. A rest two-dimensional echocardio- 
graphic examination, including standard apical and parasternal 
views of the left ventricle, was performed for each patient and 
recorded on videotape. A rest 12-lead ECG was also recorded. 
Dobutamine was administered intravenously with an infusion 
pump, starting at 10 fLg/kg body weight per rain for 3 rain 
(stage I). The infusion rate was increased by 10 ftg/kg per rain 
every 3 rain to a maximum of 40/~g/kg per rain (stage IV) and 
continued for 6 rain. If signs and symptoms of ischemia were 
absent during stage IV, atropine was given to patients who did 
not reach their age-corrected target heart rate [(220 - Age) × 
0.85 in men, and (200 - Age) × 0.85 in women]. Intravenous 
atropine was administered in 0.25-rag increments o a maxi- 
mum of 1 mg while the dobutamine infusion was continued. 
During the test, the 12-lead ECG was monitored continuously 
and recorded each minute. Blood pressure was measured 
noninvasively (Accutorr A1, Datascope Corp.) at rest and at 
each stage of the protocol. The two-dimensional echocardio- 
gram was monitored continuously and recorded on videotape 
during the last minute of each stage. A quad-screen video 
display, for side-by-side comparison of rest and stress images, 
was used during the last 150 examinations (Vingmed CFM 800, 
Diasonics Sonatron). The criteria for stopping the test in- 
cluded a decline in systolic blood pressure >40 mm Hg from 
the rest value or a systolic blood pressure <100 mm Hg, 
significant cardiac arrhythmias, evere chest pain, horizontal or 
downsloping ECG ST depression ->0.2 mV measured 80 ms 
after the J point, ST segment elevation ->0.2 mV and severe or 
extensive new echocardiographic wall motion abnormalities. 
Off-line assessment of echocardiographic images was per- 
formed by two investigators who knew the doses of dobut- 
amine and atropine used but were unaware of clinical infor- 
mation. The left ventricular wall was divided into 16 segments 
(23), and wall motion in each was subjectively scored on a 
four-point scale: 1 = normal; 2 = hypokinetic; 3 = akinetic, 
and 4 = dyskinetic. The test results were considered positive 
when wall motion in any segment deteriorated one grade or 
more. Agreement between the two investigators was required 
for test results to be designated as positive. In the event of 
disagreement, a third investigator resolved the dispute. 
For each patient, a wall motion score index (total score 
divided by the number of assessable s gments) was calculated 
at rest and during peak stress: Severity ofischemia was defined 
as the difference between these two values; extent of ischemia 
was defined as the number of segments exhibiting deteriorating 
wall motion during stress; and ischemic threshold was defined 
as the heart rate at which new echocardiographic wall motion 
abnormalities occurred, divided by the maximal age-related 
heart rate [(220 - Age) in men, and (200 - Age) in women]. 
Analysis of clinical outcomes. Patients were followed up 
throughout their stay in hospital. On the first, third and seventh 
postoperative days, serum levels of creatine kinase (CK) with 
MB fraction were measured, and a 12-lead ECG was recorded. 
These tests were repeated when necessary at the discretion of 
the treating physicians. Adverse clinical outcomes included 1) 
cardiac death (on the basis of clinical assessment, cardiac 
isoenzyme levels, the ECG and autopsy studies when avail- 
able); 2) nonfatal myocardial infarction documented bycardiac 
isoenzyme l vels (CK >110 U/liter with MB >10%) or ECG 
(new Q waves >0.03 s), or both; 3) unstable angina consisting 
of typical persisting chest pain at rest with transient ischemic 
ECG changes requiring prolonged stay or readmission to the 
intensive care unit and intravenous treatment with nitrates or 
percutaneous transluminal ngioplasty, or both. 
Statistical analysis. Univariable analysis was performed 
using the chi-square test with the Yates correction or Fisher 
exact test for categoric variables and the Student test for 
continuous variables. Multivariable logistic regression models 
were fitted in stepwise manner to identify independent predic- 
tors of a cardiac event. Only the variables ignificantly associ- 
ated with cardiac events by univariable statistics were entered 
into the multivariable analysis. The risk associated with a given 
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variable was expressed as an odds ratio with corresponding 
95% confidence intervals. Differences were considered signif- 
icant if the null hypothesis could be rejected at the 0.05 
probability level. Receiver operating characteristic curves were 
used to determine the optimal ischemic threshold for the 
prediction of cardiac events. 
Resu l ts  
Patient characteristics. The study included 302 patients 
(257 men, 45 women; mean age 67 years, range 22 to 90) with 
a history of previous myocardial infarction in 93 (3 1%), angina 
pectoris in 60 (20%) and diabetes mellitus (with drug therapy) 
in 33 (11%). Two hundred seventy-five patients had a Detsky 
score of 0 to 15 points; 23 had 16 to 30 points: and 4 had >30 
points. By the clinical risk factors of Eagle et al. (13), 100 
patients had no clinical risk factors, 179 patients one or two 
risk markers, and 21 patients had three or more risk factors. 
Dobutamine-atropine stress echocardiography. Two pa- 
tients with severe pulmonary disease were excluded from the 
study because adequate cchocardiographic images were not 
obtained. Atropine was administered in 101 of 300 patients. 
Patients taking beta-adrenergic blocking agents before the test 
required atropine more frequently (67 of 101) than those who 
were not (34 of 101) (p = 0.004). Test end points were target 
heart rate in 276 patients (92%), severe angina in 17 (5.6%) 
and side effects in 7 (2.3%). The side effects causing termina- 
tion of the test were ventricular fibrillation in one patient, 
paroxysmal trial fibrillation in two, hypotension i one, severe 
hypertension (240/130 mm Hg) in one and chills in two. 
Cardiac arrhythmias ll occurred in the recove~ phase of the 
test, and test results were available for these patients. In the 
four other patients the test was inconclusive; in the periopera- 
tive period no events occurred. 
Cardiac arrhythmias dcvelopcd in 15 patients (5%) (sus- 
tained ventricular tachycardia in 3, nonsustained ventricular 
tachycardia in 8, paroxysmal atrial fibrillation in 3). One 
patient developed ventricular fibrillation during stage IV. This 
arrhythmia was terminated with a single countershock, and the 
patient suffered no sequelae. Two patients with sustained 
ventricular tachycardia responded quickly to discontinuation 
of dobutamine, and another received intravenous metoprolol. 
Paroxysmal atrial fibrillation reverted to sinus rhythm after 
discontinuation f dobutamine plus administration f intrave- 
nous metoprolol in two patients and intravenous digoxin in 
one. Mild hypotension (decline in systolic blood pressure 
>20 mm Hg) occurred in 12 patients (4%), hypertension 
(systolic blood pressure >22(I mm Hg) in 3 (1%) and chills in 
7 (2%). 
New wall motion abnormalities occurred in 72 of 300 
patients, 12 of whom had normal wall motion at rest. Six 
patients had a left bundle branch block, making interpretation 
of ST segment changes impossible. New ST elevation or 
depression >1 mm during testing occurred in 68 patients and 
angina in 42. In all patients new wall motion abnormalities 
preceded the occurrence of stress-induced angina. 
Cardiac events. Twenty-seven patients experienced cardiac 
events between days 1 and 7 (fatal myocardial infarction in 5, 
nonfatal myocardial infarction in 12, unstable angina in 10). 
Predictive value of clinical variables and stress test. The 
Detsky score was significantly higher in patients with than 
without a cardiac event (12.0 _+ 8.1 vs. 6.5 +_ 5.4, respectively, 
p < 0.01). Cardiac events occurred in 22 of 275 low risk 
patients (0 to 15 points), 4 of 23 intermediate risk patients (16 
to 30 points) and 1 of 4 high risk patients (>30 points). 
One cardiac event occurred among 100 patients (1%) with 
no clinical risk factors (i.e., low risk) according to the criteria 
of Eagle et al. (13). The event rate was 11% (20 of 181) in 
intermediate risk patients with one or two risk factors and 
increased to 29% (6 of 21) in high risk patients with more than 
two risk factors (p < 0.001). 
Univariable analysis. Clinical variables. Significant univa- 
riable clinical predictors of perioperative events were a history 
of angina (odds ratio [OR] 4.6, 95% confidence interval [CI] 
2.0 to 10), previous myocardial infarction (OR 4.1, 95% CI 1.8 
to 9.2) and diabetes mellitus (OR 3.2, 95% CI 1.3 to 8.4). 
Other clinical variables, including age, gender, history of 
hypertension, smoking, heart failure, use of antianginal medi- 
cation and type of operation (abdominal vs. infrainguinal), 
were not predictive of perioperative vents. 
Echocardiographic variables. Perioperative cardiac events 
were more frequent in patients with echocardiographic wall 
motion abnormalities at rest (OR 3.7, 95% CI 1.6 to 8.3). All 
27 patients with a cardiac-related event had new wall motion 
abnormalities during stress. Consequently, patients with posi- 
tive test results were more likely to have a cardiac event (OR 
124, 95% CI 17 to 934). The positive predictive value of new 
wall motion abnormalities in the present study was 38% (95% 
CI 26 to 50). Ischemic ST segment changes were less strongly 
correlated with perioperative vents (OR 4.9, 95% CI 2,2 to 
11), and the occurrence of angina during stress was unrelated 
to outcome (OR 1.8, 95% CI 0.6 to 4.6). 
Multivariable analysis of clinical data and stress test results 
revealed only one independent predictor of cardiac events-- 
new wall motion abnormalities (OR 124, 95% CI 17 to 934). 
Among patients with new wall motion abnormalities, quan- 
tification of the extent and severity of stress-induced wall 
motion abnormalities was not correlated with perioperative 
cardiac events (Table 1). However, the heart rate threshold at 
which ischemia occurred provided additional prognostic infor- 
mation. Among patients with a cardiac event, the ischemic 
threshold was 67% (95% CI 63% to 71%) of the age-corrected 
maximal heart rate compared with 80% (95% CI 77 to 83) in 
patients without an event (p < 0.01). On the basis of receiver 
operating characteristic curve analysis, the best "cutoff" point 
for the heart rate ischemic threshold was estimated tobe 70%. 
There were 20 postoperative cardiac-related events among 38 
patients in whom ischemic wall motion abnormalities devel- 
oped at a heart rate <--70% of the age-corrected maximal heart 
rate (positive predictive power 53%). In contrast, here were 
seven cardiac-related vents among 34 patients with a heart 
rate threshold >70% (positive predictive power 21%). All 
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Table 1. Semiquantitative Analysis of Dobutamine-Atropine Stress Test in Patients With Positive Test 
Results: New Wall Motion Abnormalities During Stress (n = 72) 
All Cardiac Events CD/MI No Cardiac Events 
Ischemia (n = 27) (n = 17) (n = 45) p Value 
Threshold 67 (63-71) 62 (57-67) 80 (77-83) < 0.0l 
Extent 3.3 (2.3-4.3) 3.4 (2,2-4.6) 3.6 (2.5-4.7) NS 
Severity 1.5 (1.4-1.7) 1.5 (1,3-1.7) 1.6 (1.4-1.8) NS 
Data presented arc mean value (95% confidence interval). Extent = number of ischemic segments during stress; 
Severity = difference between wall motion score at peak stress and rest; Threshold - heart rate increment at which 
echocardiographic myocardial ischemia occurs [(Heart rate at ischemia - Heart rate at rest/Age-predicted maximal heart 
rate - Heart rate at rest) %]. 
patients with cardiac death had a low ischemic threshold of 
65% (95% CI 58% to 71%). 
Discussion 
The present study demonstrates the utility of dobutamine- 
atropine stress echocardiography for preoperative cardiac risk 
stratification i  candidates for major vascular surgery. The test 
was especially effective for identifying a low risk group with a 
very low incidence of perioperative cardiac complications. 
There were no cardiac events among 228 patients with negative 
test results (negative predictive power 100%, 95% CI 98% to 
100%). Positive test results greatly increased the likelihood of 
a perioperative cardiac event (OR 124, 95% CI 17 to 934) and 
was the sole independent predictor of cardiac events. Seventy- 
two patients with positive stress test results had 27 periopera- 
tive cardiac complications (positive predictive power 38%, 
95% CI 26% to 50%). 
Quantifying the extent and severity of stress-induced wall 
motion abnormalities did not provide additional risk stratifi- 
cation among patients with positive test results. However, 
consideration of the heart rate threshold at which ischemia 
occurred significantly enhanced risk stratification, lschemia 
occurred at significantly lower heart rates in patients with than 
without a cardiac event (67%, 95% CI 63% to 71% vs. 80%, 
95% CI 77% to 83%) of the age-corrected maximal heart rate). 
An ischemic threshold of 70% of the age-corrected maximal 
heart rate provided optimal risk stratification. This threshold 
defined a high risk group of 38 patients with an ischemic 
threshold (<70%) in which 20 cardiac events occurred (posi- 
tive predictive value 53%). This high risk group included all 5 
patients with cardiac-death and 8 of 12 with a nonfatal 
infarction (76% of "hard" cardiac events). There were only 
seven events in an intermediate risk group of 34 patients with 
new wall motion abnormalities at a high ischemic threshold 
(positive predictive value 21%) (Fig. 1). 
Heart rate threshold was not influenced by the concomitant 
use of beta-blockers. When the same patients were studied 
with and without beta-blockers, the heart rate at which ECG- 
detected ischemia occurred was unchanged. The dobutamine 
Figure 1. Breakdown of clinical 
variables and dobutamine stress 
test results for perioperative out- 
comes as applied to the present 
group of 300 patients. Clinical vari- 
ables are age >70 years, angina, 
diabetes requiring treatment, Q
wave on the electrocardiogram and 
history of ventricular ectopic activ- 
ity. DSE = dobutamine-atropine 
stress test; events = cardiac death, 
nonfatal myocardial infarction 
(MI) and unstable angina pectoris; 
high (low) threshold = new echo- 
cardiographic wall motion ab- 
normalities occurred at >70% 
(-<70%) of maximal ge-corrected 
heart rate; ischemic threshold = 
heart rate at which new echo- 
cardiographic wall motion abnor- 
malities occurred, divided by the 
maximal age-corrected heart rate 
(220 - Age in men, 200 - Age in 
women); neg (pos) = negative 
(positive) test results. 
I300 patients 1 
, 1 
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Table 2. Review of Value of New Wall Motion Abnormalities Detected by Stress Echocardiography for Preoperative Risk Stratification f 
Perioperative Cardiac Events in Patients Scheduled for Major Vascular Surgery 
Study 
(ref no.) Stress No. of Pts Se Sp + PV - PV No, of Events Event 
Tischler et al. (20) Dipy 11)9 88 ~8 78 99 8 CD, MI, UAP, 
CHF 
Lane et al. (17) Dobu 38 100 56 21 100 4 CD, MI, UAP 
Poldermans et al. 121) Dobu 131 100 83 42 100 15 CD, MI, UAP, 
CHF 
Lalka et al. (18) Dobu 60 85 44 20 95 13 CD, MI, UAP 
Eichelberger et al. (16) Dobu 711 1011 66 19 100 5 MI, UAP 
CD = cardiac death: CHF : congestive heart failure; Dipy : dipyridamole: D~bu - dobutamine; MI - myocardial infarction; pts - patients; ref = reference; 
Se = sensitivity (9~-); Sp = specificity (%): +PV positive predictive value (%): PV - negative predictive value (%); UAP = unstable angina pectoris. 
dose used to achieve this heart rate increased with beta- 
blocker medication. 
Our results regarding the prognostic value of the ischemic 
"threshold" during dobutarnine stress testing are in agreement 
with those reported by Cutler et al. (8) using exercise lectro- 
cardiography. They found that cardiac omplications occurred 
most frequently in patients who developed ischemic ST seg- 
ment depression at <75% of the predicted maximal age- 
related heart rate. 
Semiquantitative analysis. Quanti~'ing the extent and 
severity of stressqnduced ischemia did not enhance the pre- 
dictive power of dobutamine-atropine str ss echocardiogra- 
phy. Other investigators (24), using quantitative dipyridamole- 
thallium myocardial scintigraphy, have demonstrated that the 
extent and severity of redistribution defects enhanced the 
predictive value of this test. This discrepancy is difficult to 
explain. A tentative xplanation for these different findings is 
that dipyridamole-thallium scintigraphy detects not only myo- 
cardial ischemia, but malperfusion that may be associated with 
mild coronary artery stenoses (25). It is conceivable that such 
mild stenoses become clinically relevant if they subtend alarge 
myocardial territory. 
Side effects. The dobutamine-atropine str ss test caused 
serious complications in three patients in the present study 
(ventricular fibrillation in one, paroxysmal trial fibrillation in 
two). There were no fatal complications, which confirms 
previous findings (22) about he safety of the stress test. 
The present study has several unique features compared 
with previous echocardiographic studies: 1) We studied alarge 
group of consecutive patients; 2) test results were not used for 
clinical decision making; 3) a comprehensive analysis of stress 
test results, including severity, extent and heart rate threshold 
of ischemia, was applied. These features increase our confi- 
dence in the reliability of our results. The findings are consis- 
tent with previous work, including our own. All earlier studies 
found that preoperative pharmacologic stress echocardiogra- 
phy has excellent negative predictive power for perioperative 
cardiac events (95% to 100%) (Table 2). Moreover, most early 
studies found the positive predictive power to be relatively low 
(21% to 42%). The exception is the work of Tischler el al. (20). 
In the only study using dipyridamole stress echocardiography, 
Tischler et al. found a positive predictive power of 78%. There 
are several possible explanations for this different result: 1) 
Dipyridamole-induced ischemia might be a less sensitive but 
more specific indicator of severe coronary artery disease than 
that caused by dobutamine/atropine. Consistent with this hy- 
pothesis, the sensitivity of dipyridamole stress echocardiogra- 
phy was 88% in the study of Tischler et al. versus 100% in our 
study and two other reports (16,17,21). 2) Methodologic 
differences might explain the results. The study by Tischler et 
al. was relatively small (n = 109), and there were few cardiac 
events (n = 8). In addition, differences in study patients and 
selection criteria may have been operative. These differences 
in study design make it impossible to draw definite conclusions 
about the relative efficacy of dipyridamole or dobutamine as 
pharmacologic stressors. 
Clinical risk assessment. Our experience shows that clin- 
ical risk assessment using the Detsky scoring system is too 
insensitive for use as a screening tool in candidates for vascular 
surgery. In our study, 22 of 27 cardiac events occurred in 
patients with a relatively low Detsky score of 0 to 15 points. 
The Detsky system is a modification of the cardiac risk index of 
Goldman et al. (26), which is itself a specific but relatively 
insensitive indicator of risk. Furthermore, the cardiac risk 
index was derived from a general surgical population under- 
going a variety of surgical procedures rather than the relatively 
unique vascular surgery cohort of the present study. 
In contrast, the clinical risk factors defined by Eagle et al. 
(13) in a study of candidates for vascular surgery were useful in 
our study group. There was only one cardiac event (unstable 
angina pectoris) among 100 patients with none of the five 
clinical factors of Eagle et al. (angina, diabetes requiring drug 
therapy, age >70 years, Q wave on ECG and history of 
ventricular ectopic activity requiring treatment). The negative 
predictive power of none of the criteria of Eagle et al. was 99% 
(95% CI 98% to 100%). This finding is consistent with the 
negative predictive power of 96.9% in the study by Eagle et al. 
(13) and 96.8% noted by Lette et al. (6). This result is not 
surprising, considering that the three univariable clinical pre- 
dictors of perioperative cardiac risk that we observed (angina, 
diabetes and previous myocardial infarction) are similar to 
those seen by Eagle et al. In contrast to the study by Eagle et 
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al. (13), the positive predictive value remained present, even in 
patients with three or more cardiac risk factors. This result may 
be explained by the superior positive predictive value of 
dobutamine-atropine stress echocardiography compared with 
that for dipyridamole-thallium scintigraphy for perioperative 
cardiac events. 
On the basis of our results, we do not recommend routine 
preoperative pharmacologic stress echocardiography for all 
candidates for vascular surgery. Patients with none of the 
clinical risk factors of Eagle et al. appear to represent a low risk 
group (33% of our patients) for whom further cardiac evalu- 
ation may be unnecessary. We recommend that the remaining 
patients (with one or more clinical risk factors) undergo stress 
echocardiography preoperatively. This test identifies another 
large low risk group (70% of our remaining patients) with 
negative test results. Avoiding additional testing or expensive 
risk-reduction strategies (e.g., coronary angiography and myo- 
cardial revascularization), or both, in these patients has the 
potential to conserve health care resources. The test also 
defines an intermediate risk group with positive stress test 
results but a high ischemic threshold. The optimal manage- 
ment of these patients is unclear. 
Patients with positive pharmacologic stress test results and 
a low ischemic threshold (heart rate <70% of the age- 
corrected maximal heart rate) are at extremely high risk, and 
the advisability of operation should be carefully reconsidered. 
The optimal management of the very high risk patient who 
must undergo major vascular surgery because of life- or 
limb-threatening disease is unknown. Various risk-reduction 
strategies, including intensive perioperative monitoring and 
intervention (2,6,27), perioperative beta-adrenergic blockade 
with ultrashort-acting beta-blockers like esmolol (2), prophy- 
lactic myocardial revascularisation (3,28) and stress suppres- 
sion with regional anesthesia nd analgesia (29), have been 
proposed. However, the elficacy of these techniques has not 
been adequately investigated, and their benefits are unproved. 
Dobutamine-atropine stress echocardiography clearly iden- 
tifies a high risk group of patients in whom the utility of 
previously untested risk-reduction strategies can be prospec- 
tively assessed and may represent the most immediate appli- 
cation of the test. 
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